IMAC (BACK) Competitors $0.05 +0.00 (+0.22%) As of 04/17/2025 03:31 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock BACK vs. BTTX, UPHL, ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, and TOIIWShould you be buying IMAC stock or one of its competitors? The main competitors of IMAC include Better Therapeutics (BTTX), UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), and Oncology Institute (TOIIW). These companies are all part of the "healthcare" industry. IMAC vs. Better Therapeutics UpHealth Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute IMAC (NASDAQ:BACK) and Better Therapeutics (NASDAQ:BTTX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, community ranking, analyst recommendations, institutional ownership and risk. Does the media favor BACK or BTTX? In the previous week, IMAC had 2 more articles in the media than Better Therapeutics. MarketBeat recorded 2 mentions for IMAC and 0 mentions for Better Therapeutics. IMAC's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score. Company Overall Sentiment IMAC Neutral Better Therapeutics Neutral Does the MarketBeat Community favor BACK or BTTX? Better Therapeutics received 5 more outperform votes than IMAC when rated by MarketBeat users. Likewise, 41.67% of users gave Better Therapeutics an outperform vote while only 0.00% of users gave IMAC an outperform vote. CompanyUnderperformOutperformIMACOutperform VotesNo VotesUnderperform Votes1100.00% Better TherapeuticsOutperform Votes541.67% Underperform Votes758.33% Which has more risk and volatility, BACK or BTTX? IMAC has a beta of 1.67, suggesting that its stock price is 67% more volatile than the S&P 500. Comparatively, Better Therapeutics has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500. Which has higher valuation & earnings, BACK or BTTX? IMAC has higher revenue and earnings than Better Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIMAC$72.05K1.30-$9.42MN/AN/ABetter TherapeuticsN/AN/A-$39.76MN/AN/A Is BACK or BTTX more profitable? Company Net Margins Return on Equity Return on Assets IMACN/A N/A -325.44% Better Therapeutics N/A N/A N/A Do insiders & institutionals hold more shares of BACK or BTTX? 5.8% of IMAC shares are held by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are held by institutional investors. 12.3% of IMAC shares are held by company insiders. Comparatively, 51.4% of Better Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryBetter Therapeutics beats IMAC on 5 of the 9 factors compared between the two stocks. Get IMAC News Delivered to You Automatically Sign up to receive the latest news and ratings for BACK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BACK vs. The Competition Export to ExcelMetricIMACSpecialty outpatient clinics IndustryMedical SectorNASDAQ ExchangeMarket Cap$94,000.00$1.20B$5.31B$7.34BDividend YieldN/A1.20%5.45%4.34%P/E RatioN/A7.1021.9417.82Price / Sales1.3023.84380.6697.73Price / CashN/A8.1038.2534.64Price / Book-0.070.796.453.98Net Income-$9.42M$36.27M$3.22B$247.81M7 Day PerformanceN/A-3.99%0.74%0.28%1 Month PerformanceN/A11.32%-9.66%-7.60%1 Year PerformanceN/A-66.29%11.81%1.49% IMAC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BACKIMACN/A$0.05+0.2%N/A-98.6%$94,000.00$72,050.000.00180BTTXBetter TherapeuticsN/A$0.00-50.0%N/AN/A$5,000.00N/A0.0040Gap DownUPHLUpHealthN/A$0.00flatN/A-100.0%$4,000.00$130M0.001,750ACONWAclarionN/A$0.06+56.7%N/A+74.2%$0.00$49,289.000.007Positive NewsGap DownAONCAmerican Oncology NetworkN/A$5.15+3.0%N/A+23.0%$0.00$1.34B0.001,520Gap UpDHACWDigital Health AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$23.40+1.1%N/A+8.0%$0.00$212.45M0.00230High Trading VolumeOTRKPOntrakN/A$0.23+0.1%N/AN/A$0.00$10.84M0.00250PIIIWP3 Health PartnersN/A$0.01+10.2%N/AN/A$0.00$1.50B0.00500TALKWTalkspaceN/A$0.09+6.2%N/A-55.0%$0.00$187.59M0.00500Short Interest ↓Gap DownTOIIWOncology InstituteN/A$0.03+15.4%N/A-87.6%$0.00$393.41M0.00660Short Interest ↑Gap Up Related Companies and Tools Related Companies Better Therapeutics Competitors UpHealth Competitors Aclarion Competitors American Oncology Network Competitors Digital Health Acquisition Competitors LifeMD Competitors Ontrak Competitors P3 Health Partners Competitors Talkspace Competitors Oncology Institute Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BACK) was last updated on 4/21/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMAC Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMAC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BACK Stock Free BACK Stock Alerts